Ascendis Pharma A/S Profit Margin

As of the most recent data (June 2026), ASND shows a profit margin of 71.69%. That compares with -55.25% in the prior-year period — up 229.7% year over year. That is above the Healthcare sector average of 21.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ASND's profit margin is now 71.69% (was -55.25%) — a 229.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Ascendis Pharma A/S is outperforming or lagging.

The Healthcare sector average profit margin is about 21.34%. Ascendis Pharma A/S is at 71.69%, which is higher that average. That is roughly 236.0% above the sector mean. Use the comparison chart on this page to see how ASND stacks up against individual peers as well.

That compares with -55.25% in the prior-year period — up 229.7% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Ascendis Pharma A/S with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Ascendis Pharma A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 71.69%) with ownership activity and broader fundamentals.